Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...

The 40 patients who received GH001 saw an average 15.2 point reduction on the Montgomery-Åsberg Depression Rating Scale at Day ... early, one was related to an adverse event, the biotech added.

“Every day, the immune system is fighting ... ahead of the broad-market S&P 500’s 2.3%. Sure, these early numbers are hardly a blowout. But the outlook for biotech overall is positive, if ...

highlighting significant improvements in first-day performance for its next-generation cont Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Small biotech stocks have struggled ... Biosciences here on Seeking Alpha a few days ago recommending buying the recent dip in the stock. Since early December, five analyst firms, including ...

But these days, the competition for these assets ... the [Chinese] IPO market was almost flat for early-stage biotech companies. This was like a seismic event because it meant that you had a ...

A successful biotechnology manager must know what to expect during the early stages of a startup and ... but this does not reflect the reality of its day-to-day operation. Unfortunately, we ...

Speaking at an inauguration eve rally in Washington, Trump claimed that the forthcoming pardons would make his supporters ...